Summary: In patients with proliferative diabetic retinopathy complicated with retinal detachment, vitrectomy combined with silicone oil tamponade and dexamethasone implantation significantly reduced the incidence of preretinal proliferative membrane and macular epiretinal membrane and improved visual outcomes over a 1-year follow-up compared to vitrectomy with silicone oil tamponade alone, though it was associated with potential corticosteroid-related side effects (not specified). PICO Description Population Patients diagnosed with proliferative diabetic retinopathy complicated by retinal detachment undergoing vitrectomy. Intervention Vitrectomy combined with silicone oil tamponade and intraoperative dexamethasone implantation. Comparison Vitrectomy combined with silicone oil tamponade alone, without dexamethasone implantation. Outcome The combination therapy…
Author: FWA
Summary: In patients with type 2 diabetic bone disease characterized by low bone turnover, treatment with recombinant human parathyroid hormone rhPTH(1-34) significantly improved bone turnover markers and clinical outcomes compared to alendronate therapy, though it was associated with adverse effects typical of PTH analogs such as transient hypercalcemia and injection site reactions. PICO Description Population Adults diagnosed with type 2 diabetic bone disease exhibiting low bone turnover levels. Intervention Recombinant human parathyroid hormone rhPTH(1-34) administered subcutaneously; dosage as per study protocol. Comparison Alendronate treatment, standard antiresorptive therapy for diabetic bone disease; dosage per standard clinical practice. Outcome rhPTH(1-34) significantly increased…
Summary: In adults with STEMI undergoing primary PCI (stratified by BMI <25 vs ≥25 kg/m²), predominantly via radial access from the BRIGHT-4 trial, bivalirudin with prolonged high-dose infusion for 2-4 hours post-PCI demonstrated significant reduction in death or major bleeding in BMI <25 patients (3.2% vs 5.7%; HR 0.56) but no difference in BMI ≥25 patients (2.9% vs 2.9%) compared to heparin monotherapy during primary PCI without post-procedural infusion, with a statistically significant interaction between BMI and treatment effect (P-interaction = 0.04). PICO Description Population 6,016 adults with STEMI undergoing primary PCI, stratified by BMI (<25 kg/m² vs ≥25 kg/m²),…
Summary: In patients with diabetic foot ulcers (DFU), topical ozonated olive oil significantly improved wound healing, quality of life, glycemic control, and reduced inflammation compared to standard wound care alone, though it was associated with minimal and manageable side effects. PICO Description Population Patients with diabetic foot ulcers experiencing impaired wound healing and glycemic dysregulation. Intervention Topical application of ozonated olive oil as an adjunctive therapy to standard wound care. Comparison Standard wound care without the addition of topical ozonated olive oil. Outcome Significant enhancement in wound healing rates, improvement in quality of life scores, better glycemic control, and reduced…
Clinical Context Diabetic foot ulcers (DFUs) represent one of the most feared complications of diabetes, affecting up to 25% of patients during their lifetime and accounting for the majority of non-traumatic lower extremity amputations. Standard wound care—debridement, offloading, moisture management, and infection control—achieves complete healing in only 30-50% of cases. The persistent search for adjunctive therapies that can accelerate healing has led to exploration of numerous topical agents, including growth factors, bioengineered skin substitutes, and complementary therapies. Ozone (O₃) is a highly reactive form of oxygen with documented antimicrobial, anti-inflammatory, and tissue-healing properties. Ozone therapy has been used in medicine…
Summary: In trained adult athletes participating in a controlled energy availability study, short-term low energy availability (LEA) at 15 kcal·kg FFM⁻¹·day⁻¹, achieved with or without exercise manipulation demonstrated significant alterations in serum metabolome with shifts toward increased fat utilization, enhanced ketogenesis, reduced circulating triglycerides, and decreased amino acid concentrations compared to high energy availability (HEA) at 40 kcal·kg FFM⁻¹·day⁻¹, with metabolic changes occurring regardless of whether LEA was achieved through reduced intake or increased exercise. PICO Description Population Trained adult athletes participating in a controlled energy availability study. Intervention Short-term low energy availability (LEA) at 15 kcal·kg FFM⁻¹·day⁻¹, achieved with…
Clinical Context Diabetic foot ulcers remain a major clinical challenge, with healing rates of only 30-50% at 12 weeks using standard care. The impaired healing environment in diabetes—characterized by hyperglycemia, neuropathy, microvascular disease, chronic inflammation, and deficient growth factor signaling—creates wounds that resist closure. When standard care fails, clinicians seek advanced wound therapies that can shift the wound toward a healing trajectory. Bioactive glasses are synthetic inorganic materials that interact with biological tissues to promote regeneration. Originally developed for bone repair, bioactive glasses have shown wound healing properties through multiple mechanisms: they release ions (boron, calcium, sodium) that stimulate angiogenesis,…
Clinical Context Digital health technologies—smartphone apps, wearables, telehealth platforms—promise to transform chronic disease management by extending care beyond clinic visits into patients’ daily lives. Type 2 diabetes, with its need for ongoing self-management (diet, exercise, medication adherence, glucose monitoring), seems ideally suited for digital support. Patients make dozens of diabetes-relevant decisions daily, and real-time feedback and coaching could theoretically improve each one. The challenge lies in translating technological potential into sustained behavioral change. Many digital health interventions show short-term benefits in controlled studies but struggle with real-world implementation. User engagement typically follows a pattern: initial enthusiasm, gradual decline in app…
Clinical Context Dexamethasone is widely used perioperatively for prevention of postoperative nausea and vomiting (PONV), reduction of inflammation and edema, and potential analgesic benefits. Standard PONV prophylaxis protocols often include dexamethasone 4-8 mg as a single intraoperative dose. The drug is highly effective—reducing PONV by approximately 25%—and has become near-ubiquitous in anesthetic practice for procedures with moderate-to-high PONV risk. However, glucocorticoids are known to raise blood glucose through multiple mechanisms: they increase hepatic gluconeogenesis, induce insulin resistance, and impair peripheral glucose uptake. For patients with diabetes, there has been longstanding concern that even a single dose of dexamethasone might cause…
Clinical Context Dexamethasone is a cornerstone of modern anesthetic practice, widely used for prevention of postoperative nausea and vomiting (PONV). Standard PONV prophylaxis protocols typically include dexamethasone 4-8 mg as a single intraoperative dose, which reduces PONV by approximately 25%. The drug also provides anti-inflammatory benefits that may reduce surgical swelling and improve early recovery. However, glucocorticoids predictably elevate blood glucose through multiple mechanisms: increased hepatic gluconeogenesis, peripheral insulin resistance, and direct pancreatic effects. For patients with diabetes, this hyperglycemic effect raises concerns about perioperative glucose management, wound healing, and infection risk. The question of whether a single prophylactic dexamethasone…